These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 25064580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention.
    Cadeddu Dessalvi C, Deidda M, Mele D, Bassareo PP, Esposito R, Santoro C, Lembo M, Galderisi M, Mercuro G.
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
    Ky B, Carver JR.
    Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
    [Abstract] [Full Text] [Related]

  • 5. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.
    Adão R, de Keulenaer G, Leite-Moreira A, Brás-Silva C.
    Rev Port Cardiol; 2013 May; 32(5):395-409. PubMed ID: 23623503
    [Abstract] [Full Text] [Related]

  • 6. Anthracycline-related cardiotoxicity in childhood cancer survivors.
    Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL.
    Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
    [Abstract] [Full Text] [Related]

  • 7. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
    Nelson-Veniard M, Thambo JB.
    Bull Cancer; 2015 Jan; 102(7-8):622-6. PubMed ID: 25935231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular disease in survivors of childhood cancer.
    Bansal N, Amdani SM, Hutchins KK, Lipshultz SE.
    Curr Opin Pediatr; 2018 Oct; 30(5):628-638. PubMed ID: 30124579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
    Raschi E, Vasina V, Ursino MG, Boriani G, Martoni A, De Ponti F.
    Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849
    [Abstract] [Full Text] [Related]

  • 17. Prevention and management of cardiotoxicity from antineoplastic therapy.
    Chanan-Khan A, Srinivasan S, Czuczman MS.
    J Support Oncol; 2004 Feb; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.